Last 12 months
Inside the activity.
3 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2025 Filed Jun 5, 2025 21:35 UTC |
Jain Mudit K.Director
|
GrantStock Option (right to buy) · Derivative | 19,554 | $0.00 Strike: $6.76 | $0.00 |
DisclosureSEC source: 0001415889-25-015815 · form4-06052025_090637.xml · derivative · entry 1 Jain Mudit K. · CIK 0001584404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,554 Underlying: Common Stock · 19,554 shares Expires 2035-06-03 F1 · derivative.exercise_date: Vests on the earlier of June 3, 2026 or the Issuer's 2026 annual meeting of stockholders. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 21:17 UTC |
Hill, Mitch C.Director
|
GrantStock Option (right to buy) · Derivative | 19,554 | $0.00 Strike: $6.76 | $0.00 |
DisclosureSEC source: 0001415889-25-015808 · form4-06052025_090604.xml · derivative · entry 1 Hill, Mitch C. · CIK 0001644989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,554 Underlying: Common Stock · 19,554 shares Expires 2035-06-03 F1 · derivative.exercise_date: Vests on the earlier of June 3, 2026 or the Issuer's 2026 annual meeting of stockholders. Read SEC document |
| June 03, 2025 Filed Jun 5, 2025 21:13 UTC |
Ballinger Kevin J.Director
|
GrantStock Option (right to buy) · Derivative | 19,554 | $0.00 Strike: $6.76 | $0.00 |
DisclosureSEC source: 0001415889-25-015807 · form4-06052025_090656.xml · derivative · entry 1 Ballinger Kevin J. · CIK 0001566080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,554 Underlying: Common Stock · 19,554 shares Expires 2035-06-03 F1 · derivative.exercise_date: Vests on the earlier of June 3, 2026 or the Issuer's 2026 annual meeting of stockholders. Read SEC document |
| May 15, 2025 Filed May 19, 2025 22:46 UTC |
Nielsen Kirk G.Director
|
PurchaseCommon Stock | 10,966 | $5.45 | $59,795.40 |
DisclosureSEC source: 0000950170-25-074682 · ownership.xml · nonDerivative · entry 1 Nielsen Kirk G. · CIK 0001523522 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,910,134 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.37 to $5.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · ownership.nature: These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares. Read SEC document |
| May 14, 2025 Filed May 14, 2025 21:27 UTC |
Nielsen Kirk G.Director
|
PurchaseCommon Stock | 61,200 | $5.23 | $320,363.64 |
DisclosureSEC source: 0000950170-25-071629 · ownership.xml · nonDerivative · entry 3 Nielsen Kirk G. · CIK 0001523522 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,899,168 F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.07 to $5.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (4) to this Form 4. F2 · ownership.nature: These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares. Read SEC document |
| May 13, 2025 Filed May 13, 2025 23:12 UTC |
Jain Mudit K.Director
|
PurchaseCommon Stock | 150 | $5.26 | $789.00 |
DisclosureSEC source: 0001415889-25-012825 · form4-05132025_110536.xml · nonDerivative · entry 2 Jain Mudit K. · CIK 0001584404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,050 Read SEC document |
| May 13, 2025 Filed May 14, 2025 21:27 UTC |
Nielsen Kirk G.Director
|
PurchaseCommon Stock | 101,413 | $5.29 | $536,312.51 |
DisclosureSEC source: 0000950170-25-071629 · ownership.xml · nonDerivative · entry 2 Nielsen Kirk G. · CIK 0001523522 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,837,968 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.89 to $5.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3) to this Form 4. F2 · ownership.nature: These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares. Read SEC document |
| May 12, 2025 Filed May 12, 2025 19:07 UTC |
Hykes KevinDirector · PRES & CEO
|
PurchaseCommon Stock | 5,000 | $4.84 | $24,200.00 |
DisclosureSEC source: 0001415889-25-012699 · form4-05122025_110541.xml · nonDerivative · entry 1 Hykes Kevin · CIK 0001467748 · Director · PRES & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,000 Read SEC document |
| May 12, 2025 Filed May 13, 2025 23:12 UTC |
Jain Mudit K.Director
|
PurchaseCommon Stock | 1,500 | $4.66 | $6,985.95 |
DisclosureSEC source: 0001415889-25-012825 · form4-05132025_110536.xml · nonDerivative · entry 1 Jain Mudit K. · CIK 0001584404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,900 F1 · price: Reflects the weighted average price of 1,500 shares of common stock of CVRx, Inc. purchased by the reporting person in multiple transactions on May 12, 2025 with purchase prices ranging from $4.52 to $4.76 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 12, 2025 Filed May 14, 2025 21:27 UTC |
Nielsen Kirk G.Director
|
PurchaseCommon Stock | 25,200 | $4.79 | $120,670.20 |
DisclosureSEC source: 0000950170-25-071629 · ownership.xml · nonDerivative · entry 1 Nielsen Kirk G. · CIK 0001523522 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,736,555 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.65 to $4.845, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · ownership.nature: These shares are held directly by Vensana Capital I, L.P. ("Vensana I"). The Reporting Person is a Managing Director of Vensana Capital I GP, LLC, the General Partner of Vensana I, and shares voting and dispositive power over the shares held by Vensana I. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 16:11 UTC |
Adamson Philip B.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001415889-25-006481 · form4-03042025_090314.xml · derivative · entry 2 Adamson Philip B. · CIK 0002056191 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2035-02-27 F2 · derivative.exercise_date: Vests as to 25% of the shares on February 28, 2026 and as to 1/48th of the shares each month thereafter. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 16:11 UTC |
Adamson Philip B.Chief Medical Officer
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-006481 · form4-03042025_090314.xml · nonDerivative · entry 1 Adamson Philip B. · CIK 0002056191 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 16:12 UTC |
John Robert AllenChief Revenue Officer
|
GrantStock Option (right to buy) · Derivative | 38,000 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001415889-25-006485 · form4-03042025_090310.xml · derivative · entry 2 John Robert Allen · CIK 0002028875 · Chief Revenue Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,000 Underlying: Common Stock · 38,000 shares Expires 2035-02-27 F2 · derivative.exercise_date: Vests as to 25% of the shares on February 28, 2026 and as to 1/48th of the shares each month thereafter. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 16:12 UTC |
John Robert AllenChief Revenue Officer
|
GrantCommon Stock | 55,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-006485 · form4-03042025_090310.xml · nonDerivative · entry 1 John Robert Allen · CIK 0002028875 · Chief Revenue Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 16:11 UTC |
OASHEIM JAREDCHIEF FINANCIAL OFFICER
|
GrantStock Option (right to buy) · Derivative | 33,000 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001415889-25-006483 · form4-03042025_090345.xml · derivative · entry 2 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,000 Underlying: Common Stock · 33,000 shares Expires 2035-02-27 F2 · derivative.exercise_date: Vests as to 25% of the shares on February 28, 2026 and as to 1/48th of the shares each month thereafter. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 16:11 UTC |
OASHEIM JAREDCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 22,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-006483 · form4-03042025_090345.xml · nonDerivative · entry 1 OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,447 F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 16:10 UTC |
VERRASTRO PAULCHIEF MKTG & STRAT OFFICER
|
GrantStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001415889-25-006480 · form4-03042025_090333.xml · derivative · entry 2 VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2035-02-27 F2 · derivative.exercise_date: Vests as to 25% of the shares on February 28, 2026 and as to 1/48th of the shares each month thereafter. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 16:10 UTC |
VERRASTRO PAULCHIEF MKTG & STRAT OFFICER
|
GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-006480 · form4-03042025_090333.xml · nonDerivative · entry 1 VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,835 F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 16:13 UTC |
Hykes KevinDirector · PRES & CEO
|
GrantStock Option (right to buy) · Derivative | 148,000 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001415889-25-006488 · form4-03042025_090317.xml · derivative · entry 2 Hykes Kevin · CIK 0001467748 · Director · PRES & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,000 Underlying: Common Stock · 148,000 shares Expires 2035-02-27 F2 · derivative.exercise_date: Vests as to 25% of the shares on February 28, 2026 and as to 1/48th of the shares each month thereafter. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 16:13 UTC |
Hykes KevinDirector · PRES & CEO
|
GrantCommon Stock | 98,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-006488 · form4-03042025_090317.xml · nonDerivative · entry 1 Hykes Kevin · CIK 0001467748 · Director · PRES & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,000 F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date. Read SEC document |
| November 21, 2024 Filed Nov 21, 2024 19:05 UTC |
VERRASTRO PAULCHIEF MKTG & STRAT OFFICER
|
GiftCommon Stock | 1,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-027467 · form4-11222024_121153.xml · nonDerivative · entry 3 VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 835 Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 19:05 UTC |
VERRASTRO PAULCHIEF MKTG & STRAT OFFICER
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $5.14 | $0.00 |
DisclosureSEC source: 0001415889-24-027467 · form4-11222024_121153.xml · derivative · entry 4 VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,306 Underlying: Common Stock · 2,500 shares Expires 2031-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vested as to 25% of the shares on January 4, 2022 and vests as to 1/48th of the shares each month thereafter. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 19:05 UTC |
VERRASTRO PAULCHIEF MKTG & STRAT OFFICER
|
SaleCommon Stock | 1,430 | $13.58 | $19,416.68 |
DisclosureSEC source: 0001415889-24-027467 · form4-11222024_121153.xml · nonDerivative · entry 2 VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,875 F1 · price: Reflects the weighted average price of 1,430 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on November 19, 2024 with sale prices ranging from $13.525 to $13.64 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 19:05 UTC |
VERRASTRO PAULCHIEF MKTG & STRAT OFFICER
|
Exercise / conversionCommon Stock | 2,500 | $5.14 | $12,852.50 |
DisclosureSEC source: 0001415889-24-027467 · form4-11222024_121153.xml · nonDerivative · entry 1 VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,305 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:44 UTC |
Ballinger Kevin J.Director
|
GrantStock Option (right to buy) · Derivative | 36,136 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001415889-24-022938 · form4-09052024_080958.xml · derivative · entry 1 Ballinger Kevin J. · CIK 0001566080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,136 Underlying: Common Stock · 36,136 shares Expires 2034-09-02 F1 · derivative.exercise_date: Vests as to one-third of the shares on each annual anniversary of the date of grant. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:43 UTC |
Hill, Mitch C.Director
|
GrantStock Option (right to buy) · Derivative | 36,136 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001415889-24-022937 · form4-09052024_080937.xml · derivative · entry 1 Hill, Mitch C. · CIK 0001644989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,136 Underlying: Common Stock · 36,136 shares Expires 2034-09-02 F1 · derivative.exercise_date: Vests as to one-third of the shares on each annual anniversary of the date of grant. Read SEC document |
| August 15, 2024 Filed Aug 15, 2024 23:18 UTC |
SLATTERY JOSEPH PDirector
|
PurchaseCommon Stock | 3,000 | $8.10 | $24,300.00 |
DisclosureSEC source: 0001415889-24-021415 · form4-08152024_110829.xml · nonDerivative · entry 1 SLATTERY JOSEPH P · CIK 0001246530 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,645 Read SEC document |
| August 08, 2024 Filed Aug 8, 2024 20:18 UTC |
SLATTERY JOSEPH PDirector
|
PurchaseCommon Stock | 3,000 | $8.24 | $24,715.80 |
DisclosureSEC source: 0001415889-24-020981 · form4-08082024_080802.xml · nonDerivative · entry 1 SLATTERY JOSEPH P · CIK 0001246530 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,645 Read SEC document |
| August 06, 2024 Filed Aug 6, 2024 20:43 UTC |
SLATTERY JOSEPH PDirector
|
PurchaseCommon Stock | 2,500 | $9.09 | $22,725.00 |
DisclosureSEC source: 0001415889-24-020841 · form4-08062024_080850.xml · nonDerivative · entry 1 SLATTERY JOSEPH P · CIK 0001246530 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,645 Read SEC document |
| August 05, 2024 Filed Aug 5, 2024 16:56 UTC |
Hykes KevinDirector · PRES & CEO
|
PurchaseCommon Stock | 30,000 | $8.36 | $250,767.00 |
DisclosureSEC source: 0001415889-24-020762 · form4-08052024_080830.xml · nonDerivative · entry 1 Hykes Kevin · CIK 0001467748 · Director · PRES & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 F1 · price: Reflects the weighted average price of 30,000 shares of common stock of CVRx, Inc. purchased by the reporting person in multiple transactions on August 5, 2024 with purchase prices ranging from $8.245 to $8.47 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 16:45 UTC |
Hykes KevinDirector · PRES & CEO
|
GrantStock Option (right to buy) · Derivative | 180,000 | $0.00 Strike: $8.55 | $0.00 |
DisclosureSEC source: 0001415889-24-020639 · form4-08022024_080824.xml · derivative · entry 1 Hykes Kevin · CIK 0001467748 · Director · PRES & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2034-07-30 F1 · derivative.exercise_date: Vests as to 25% of the shares on July 31, 2025 and as to 1/48th of the shares each month thereafter. Read SEC document |
| June 27, 2024 Filed Jul 1, 2024 17:29 UTC |
John Robert AllenChief Revenue Officer
|
GrantStock Option (right to buy) · Derivative | 122,192 | $0.00 Strike: $11.70 | $0.00 |
DisclosureSEC source: 0001415889-24-018643 · form4-07012024_090702.xml · derivative · entry 1 John Robert Allen · CIK 0002028875 · Chief Revenue Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,192 Underlying: Common Stock · 122,192 shares Expires 2034-06-26 F1 · derivative.exercise_date: Vests as to 25% of the shares on June 27, 2025 and as to 1/48th of the shares each month thereafter. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 23:05 UTC |
SHADAN MARTHADirector
|
GrantStock Option (right to buy) · Derivative | 20,961 | $0.00 Strike: $6.49 | $0.00 |
DisclosureSEC source: 0001415889-24-015847 · form4-06062024_110622.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,961 Underlying: Common Stock · 20,961 shares Expires 2034-06-04 F1 · derivative.exercise_date: Vests on the earlier of June 4, 2025 or the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 23:07 UTC |
SLATTERY JOSEPH PDirector
|
GrantStock Option (right to buy) · Derivative | 20,961 | $0.00 Strike: $6.49 | $0.00 |
DisclosureSEC source: 0001415889-24-015849 · form4-06062024_110613.xml · derivative · entry 1 SLATTERY JOSEPH P · CIK 0001246530 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,961 Underlying: Common Stock · 20,961 shares Expires 2034-06-04 F1 · derivative.exercise_date: Vests on the earlier of June 4, 2025 or the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| June 04, 2024 Filed Jun 7, 2024 00:35 UTC |
Behbahani AliDirector
|
GrantStock Option (right to buy) · Derivative | 20,961 | $0.00 Strike: $6.49 | $0.00 |
DisclosureSEC source: 0000950170-24-070151 · ownership.xml · derivative · entry 1 Behbahani Ali · CIK 0001613867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,961 Underlying: Common Stock · 20,961 shares Expires 2034-06-04 F1 · derivative.exercise_date: Vests on the earlier of June 4, 2025 or the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 23:05 UTC |
Nielsen Kirk G.Director
|
GrantStock Option (right to buy) · Derivative | 20,961 | $0.00 Strike: $6.49 | $0.00 |
DisclosureSEC source: 0001415889-24-015846 · form4-06062024_110608.xml · derivative · entry 1 Nielsen Kirk G. · CIK 0001523522 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,961 Underlying: Common Stock · 20,961 shares Expires 2034-06-04 F1 · derivative.exercise_date: Vests on the earlier of June 4, 2025 or the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 23:06 UTC |
Jain Mudit K.Director
|
GrantStock Option (right to buy) · Derivative | 20,961 | $0.00 Strike: $6.49 | $0.00 |
DisclosureSEC source: 0001415889-24-015848 · form4-06062024_110632.xml · derivative · entry 1 Jain Mudit K. · CIK 0001584404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,961 Underlying: Common Stock · 20,961 shares Expires 2034-06-04 F1 · derivative.exercise_date: Vests on the earlier of June 4, 2025 or the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| June 04, 2024 Filed Jun 7, 2024 21:16 UTC Amendment |
SHADAN MARTHADirector
|
GrantStock Option (right to buy) · Derivative | 27,250 | $0.00 Strike: $6.49 | $0.00 |
DisclosureSEC source: 0001415889-24-016034 · form4a-06072024_090624.xml · derivative · entry 1 SHADAN MARTHA · CIK 0001871700 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,250 Underlying: Common Stock · 27,250 shares Expires 2034-06-04 F1 · shares: The reporting person's Form 4 filed on June 6, 2024 inadvertently understated the reporting person's stock options granted by 6,289. F2 · derivative.exercise_date: Vests on the earlier of June 4, 2025 or the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| June 04, 2024 Filed Jun 7, 2024 21:18 UTC Amendment |
SLATTERY JOSEPH PDirector
|
GrantStock Option (right to buy) · Derivative | 27,250 | $0.00 Strike: $6.49 | $0.00 |
DisclosureSEC source: 0001415889-24-016037 · form4a-06072024_090606.xml · derivative · entry 1 SLATTERY JOSEPH P · CIK 0001246530 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,250 Underlying: Common Stock · 27,250 shares Expires 2034-06-04 F1 · shares: The reporting person's Form 4 filed on June 6, 2024 inadvertently understated the reporting person's stock options granted by 6,289. F2 · derivative.exercise_date: Vests on the earlier of June 4, 2025 or the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| June 04, 2024 Filed Jun 7, 2024 21:25 UTC Amendment |
Behbahani AliDirector
|
GrantStock Option (right to buy) · Derivative | 27,250 | $0.00 Strike: $6.49 | $0.00 |
DisclosureSEC source: 0000950170-24-070916 · ownership.xml · derivative · entry 1 Behbahani Ali · CIK 0001613867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,250 Underlying: Common Stock · 27,250 shares Expires 2034-06-04 F1 · shares: The reporting person's Form 4 filed on June 6, 2024 inadvertently understated the reporting person's stock options granted by 6,289. F2 · derivative.exercise_date: Vests on the earlier of June 4, 2025 or the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| June 04, 2024 Filed Jun 7, 2024 21:18 UTC Amendment |
Nielsen Kirk G.Director
|
GrantStock Option (right to buy) · Derivative | 27,250 | $0.00 Strike: $6.49 | $0.00 |
DisclosureSEC source: 0001415889-24-016039 · form4a-06072024_090647.xml · derivative · entry 1 Nielsen Kirk G. · CIK 0001523522 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,250 Underlying: Common Stock · 27,250 shares Expires 2034-06-04 F1 · shares: The reporting person's Form 4 filed on June 6, 2024 inadvertently understated the reporting person's stock options granted by 6,289. F2 · derivative.exercise_date: Vests on the earlier of June 4, 2025 or the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| June 04, 2024 Filed Jun 7, 2024 21:17 UTC Amendment |
Jain Mudit K.Director
|
GrantStock Option (right to buy) · Derivative | 27,250 | $0.00 Strike: $6.49 | $0.00 |
DisclosureSEC source: 0001415889-24-016035 · form4a-06072024_090615.xml · derivative · entry 1 Jain Mudit K. · CIK 0001584404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,250 Underlying: Common Stock · 27,250 shares Expires 2034-06-04 F1 · shares: The reporting person's Form 4 filed on June 6, 2024 inadvertently understated the reporting person's stock options granted by 6,289. F2 · derivative.exercise_date: Vests on the earlier of June 4, 2025 or the Issuer's 2025 annual meeting of stockholders. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:56 UTC |
Palmer Craig E.SVP, U.S. SALES
|
Exercise / conversionStock Option (right to buy) · Derivative | 151 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001415889-24-009216 · form4-03272024_080333.xml · derivative · entry 6 Palmer Craig E. · CIK 0001907440 · SVP, U.S. SALES 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 151 shares Expires 2025-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:56 UTC |
Palmer Craig E.SVP, U.S. SALES
|
Exercise / conversionStock Option (right to buy) · Derivative | 404 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001415889-24-009216 · form4-03272024_080333.xml · derivative · entry 5 Palmer Craig E. · CIK 0001907440 · SVP, U.S. SALES 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 404 shares Expires 2025-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:56 UTC |
Palmer Craig E.SVP, U.S. SALES
|
Exercise / conversionStock Option (right to buy) · Derivative | 379 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001415889-24-009216 · form4-03272024_080333.xml · derivative · entry 4 Palmer Craig E. · CIK 0001907440 · SVP, U.S. SALES 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 379 shares Expires 2024-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:56 UTC |
Palmer Craig E.SVP, U.S. SALES
|
Exercise / conversionCommon Stock | 151 | $0.24 | $35.79 |
DisclosureSEC source: 0001415889-24-009216 · form4-03272024_080333.xml · nonDerivative · entry 3 Palmer Craig E. · CIK 0001907440 · SVP, U.S. SALES 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:56 UTC |
Palmer Craig E.SVP, U.S. SALES
|
Exercise / conversionCommon Stock | 404 | $0.24 | $95.75 |
DisclosureSEC source: 0001415889-24-009216 · form4-03272024_080333.xml · nonDerivative · entry 2 Palmer Craig E. · CIK 0001907440 · SVP, U.S. SALES 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:56 UTC |
Palmer Craig E.SVP, U.S. SALES
|
Exercise / conversionCommon Stock | 379 | $0.24 | $89.82 |
DisclosureSEC source: 0001415889-24-009216 · form4-03272024_080333.xml · nonDerivative · entry 1 Palmer Craig E. · CIK 0001907440 · SVP, U.S. SALES 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 29, 2024 Filed Mar 6, 2024 20:42 UTC |
JOHNSON & JOHNSON10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 79 | $0.00 Strike: $5.14 | $0.00 |
DisclosureSEC source: 0000950170-24-027095 · ownership.xml · derivative · entry 33 JOHNSON & JOHNSON · CIK 0000200406 · 10% owner Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Johnson & Johnson Innovation - JJDC, Inc. Disclosed balance after: 0 Underlying: Common Stock · 79 shares Expires 2031-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. F9 · balance_after: 1,185 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value. F1 · ownership.nature: The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"), a wholly-owned subsidiary of Johnson & Johnson. Read SEC document |
| February 29, 2024 Filed Mar 6, 2024 20:42 UTC |
JOHNSON & JOHNSON10% owner
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 252 | $0.00 Strike: $3.96 | $0.00 |
DisclosureSEC source: 0000950170-24-027095 · ownership.xml · derivative · entry 32 JOHNSON & JOHNSON · CIK 0000200406 · 10% owner Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Johnson & Johnson Innovation - JJDC, Inc. Disclosed balance after: 0 Underlying: Common Stock · 252 shares Expires 2029-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. F8 · balance_after: 506 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value. F1 · ownership.nature: The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"), a wholly-owned subsidiary of Johnson & Johnson. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.